VCAM‐1 targeted delivery of liposomes loaded with a CCR2 antagonist enabled specific delivery to the cancer cell‐activated endothelium36 In addition, lipid micelles composed of PEG‐distearoylphosphatidylethanolamine have high biocompatibility and can solubilize hydrophobic CCR2 inhibitors.37 This evidence concerns the gene CCR2 and cancer.